Project 2 - Shh and Etv2 Signaling Pathways and Cardiovascular Repair in Mouse and Pig

项目 2 - Shh 和 Etv2 信号通路以及小鼠和猪的心血管修复

• 批准号: 10677734
• 负责人: Daniel J. Garry
• 金额: $ 43万
• 依托单位: UNIVERSITY OF ALABAMA AT BIRMINGHAM
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-01 至 2027-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10677734
• 关键词: Adult; Algorithms; Animal Model; Applications Grants; Bioinformatics; Birth; Blood Vessels; Cardiac; Cardiac Myocytes; Cardiovascular Diseases; Cardiovascular system; Cell Proliferation; Clinical Research; Collaborations; Complement; Data; Development; Dissection; Endothelium; Engineering; Family suidae; Future; Gene Expression; Genetic; Genetic Engineering; Genetic Models; Goals; Growth; Heart; Heart Diseases; Heart Injuries; Heart failure; In Vitro; Injury; Ischemia; Knock-out; Laboratories; Lower Organism; Messenger RNA; Molecular; Molecular Analysis; Morbidity - disease rate; Mus; Muscle; Myocardial Infarction; Natural regeneration; Neonatal; Newts; Pathway interactions; Patient Care; Patients; Proliferating; Publications; Publishing; Regenerative capacity; Role; SOX4 gene; Signal Pathway; Societies; Techniques; Technology; Testing; Therapeutic; Tissues; Ventricular; Viral Vector; angiogenesis; cardiac regeneration; cardiac repair; clinically significant; congenital heart disorder; experimental study; heart cell; injured; innovation; mortality; mouse model; myocardial injury; novel; novel therapeutics; overexpression; porcine model; postnatal; pre-clinical; programs; repaired; synergism; tool

ABSTRACT Cardiovascular disease is common and deadly. While lower organisms have a tremendous capacity for regeneration, the adult mammalian heart is more limited in its capacity for regeneration and remuscularization of the damaged tissue following an injury such as a myocardial infarction. Recently, we defined an evolutionary conserved Shh signaling pathway in newt and mouse that promotes cardiomyocyte proliferation in vitro and cardiac repair. Our preliminary data support the hypothesis that Gli1 (a downstream effector of Shh) is a direct upstream regulator of Sox4 gene expression and Gli1 overexpression promotes cardiomyocyte proliferation in vitro. Furthermore, we have demonstrated that Etv2 is a master regulator of the endothelial lineage and is necessary and sufficient for angiogenesis in mouse and pig. Importantly, the results of these studies provide a platform for the proposed studies that will dissect the mechanisms that govern cardiovascular repair and proliferation. Therefore, our overall hypothesis is that the Shh downstream effectors, Gli1/Gli2, regulate cardiomyocyte proliferation in a Sox4 dependent manner and Etv2 promotes endothelial/vascular development to collectively promote cardiac regeneration. In these proposed studies, we will use a number of novel genetic models and large animal models that are available in our laboratory (and the cores), bioinformatics algorithms that we developed and we take an innovative approach to dissect the role of Gli1, Etv2 and Sox4 as important factors that govern cardiovascular repair and proliferation. To examine our hypotheses, the revised Project 2 proposal will address the following specific aims: Specific Aim #1: To define the capacity of Gli and Etv2 deficient hearts for growth and regeneration; Specific Aim #2: To determine the impact of Gli1 and Etv2 overexpression on cardiac repair and regeneration and Specific Aim #3: To define the mechanistic role of Sox4 in the cardiomyocyte lineage. These aims will complement and synergize with the other projects. They will utilize our recently engineered genetic mouse models, inducible viral vectors, modified mRNA-GFP constructs, mouse and pig models, molecular analyses and bioinformatics algorithms to comprehensively define the role for Gli1, Etv2 and Sox4 as essential factors that govern cardiac repair and regeneration by promoting cardiomyocyte proliferation and angiogenesis following injury. Given the tremendous morbidity and mortality of cardiovascular disease in our society, the potential impact of this proposal is tremendous.

摘要 心血管疾病是常见且致命的。虽然低等生物有巨大的能力 成年哺乳动物心脏的再生能力和肌肉再生能力有限 心肌梗塞等损伤后受损组织的损伤。最近，我们定义了一种进化的 蝾螈和小鼠中保守的Shh信号通路，促进体外心肌细胞增殖， 心脏修复我们的初步数据支持这样的假设，即Gli 1（Shh的下游效应子）是一个直接的细胞因子。 Sox 4基因表达和Gli 1过表达的上游调节因子促进心肌细胞增殖， 体外此外，我们已经证明Etv 2是内皮细胞谱系的主要调节因子， 是小鼠和猪血管生成所必需的和足够的。重要的是，这些研究的结果提供了一个 为拟议的研究提供平台，这些研究将剖析管理心血管修复的机制， 增殖因此，我们的总体假设是，Shh下游效应子Gli 1/Gli 2， 心肌细胞以Sox 4依赖性方式增殖，Etv 2促进内皮/血管 共同促进心脏再生。在这些拟议的研究中，我们将使用 在我们的实验室（和核心）中可获得的许多新的遗传模型和大型动物模型， 我们开发的生物信息学算法，我们采用创新的方法来剖析Gli 1的作用， Etv 2和Sox 4是控制心血管修复和增殖的重要因素。审视我们 假设，修订后的项目2提案将解决以下具体目标：具体目标#1： 定义Gli和Etv 2缺陷心脏的生长和再生能力;具体目标#2： 确定Gli 1和Etv 2过表达对心脏修复和再生的影响， 目的#3：确定Sox 4在心肌细胞谱系中的机制作用。这些目标将 与其他项目相辅相成。他们将利用我们最近改造的基因小鼠 模型、诱导型病毒载体、修饰的mRNA-GFP构建体、小鼠和猪模型、分子分析 和生物信息学算法来全面定义Gli 1、Etv 2和Sox 4作为基本因子的作用 通过促进心肌细胞增殖和血管生成来管理心脏修复和再生 受伤后。鉴于我们社会中心血管疾病的发病率和死亡率非常高， 这项建议的潜在影响是巨大的。